Загрузка...
Rituximab for Rheumatoid Arthritis
Rituximab is a chimeric monoclonal antibody directed at the CD20 molecule on the surfaces of some but not all B cells. It depletes almost all peripheral B cells, but other niches of B cells are variably depleted, including synovium. Its mechanism of action in rheumatoid arthritis (RA) is only partia...
Сохранить в:
| Опубликовано в: : | Rheumatol Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883263/ https://ncbi.nlm.nih.gov/pubmed/27747531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-015-0016-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|